NYSE:TFX
Teleflex Incorporated Stock News
$207.38
-0.92 (-0.442%)
At Close: Apr 18, 2024
Teleflex, Inc. (TFX) Q3 2022 Earnings Call Transcript
04:03pm, Thursday, 27'th Oct 2022
Teleflex, Inc. (NYSE:TFX ) Q3 2022 Earnings Conference Call October 27, 2022 8:00 AM ET Company Participants Lawrence Keusch - Vice President of Investor Relations & Strategy Development Liam Kelly -
Teleflex Announces Third Quarter 2022 Earnings Conference Call Information
06:30am, Thursday, 13'th Oct 2022
WAYNE, Pa., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m.
Teleflex (TFX) Witnesses Lower UroLift Sales, Cost Woes
12:47pm, Monday, 19'th Sep 2022
Teleflex's (TFX) lowered revenue and adjusted EPS outlook for 2022 indicates lackluster performance, which increases investors' concern.
Results from Largest Ever Real-World Evaluation of the MANTA® Device Demonstrated Safety and Effectiveness with Low Complication Rates and a Short Learning Curve Results from Largest Ever Real-World
Teleflex to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
06:30am, Wednesday, 31'st Aug 2022
WAYNE, Pa., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 20th Annual Global Healthcare Conf
Teleflex, Inc. (TFX) CEO Liam Kelly on Q2 2022 Results - Earnings Call Transcript
02:34pm, Thursday, 28'th Jul 2022
Teleflex, Inc. (NYSE:TFX ) Q2 2022 Earnings Conference Call July 28, 2022 8:00 AM ET Company Participants Lawrence Keusch - VP, IR & Strategy Development Liam Kelly - Chairman, President & CEO Thomas
Teleflex (TFX) Q2 Earnings Beat Estimates
09:23am, Thursday, 28'th Jul 2022
Teleflex (TFX) delivered earnings and revenue surprises of 1.19% and 2.32%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Teleflex Announces Second Quarter 2022 Earnings Conference Call Information
06:30am, Thursday, 14'th Jul 2022
WAYNE, Pa., July 14, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m
Here's Why You Should Hold on to Teleflex (TFX) Stock for Now
12:24pm, Tuesday, 14'th Jun 2022
Investors are optimistic about Teleflex's (TFX) better-than-expected results and strong growth within the vascular business.
Teleflex's (TFX) Q1 Earnings Top Estimates, Margins Down
12:02pm, Friday, 29'th Apr 2022
Teleflex (TFX) exhibits year-over-year growth across the Americas, EMEA and Asia regions at CER in the first quarter.
Teleflex Incorporated (TFX) CEO Liam Kelly on Q1 2022 Results - Earnings Call Transcript
11:36am, Thursday, 28'th Apr 2022
Teleflex Incorporated (NYSE:TFX ) Q1 2022 Earnings Conference Call April 28, 2022 8:00 AM ET Company Participants Lawrence Keusch - VP, Investor Relations and Strategy Development Liam Kelly - Chairma
Teleflex to Present at the Bank of America Securities 2022 Healthcare Conference
06:30am, Tuesday, 26'th Apr 2022
WAYNE, Pa., April 26, 2022 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2022 Healthcare Confe
Teleflex Announces First Quarter 2022 Earnings Conference Call Information
06:30am, Thursday, 14'th Apr 2022
WAYNE, Pa., April 14, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter 2022 results, and provide an operational update at 8:00 a.m. Ea
Teleflex: Diversified Portfolio Of Medical Devices At A Convenient Stock Price
09:15am, Wednesday, 23'rd Mar 2022
Teleflex: Diversified Portfolio Of Medical Devices At A Convenient Stock Price
Global Central Venous Catheters (CVCs) Market to Reach $1.5 Billion by 2026
04:26pm, Friday, 11'th Mar 2022 Benzinga
SAN FRANCISCO , March 11, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Central Venous Catheters (CVCs) - Global Market Trajectory & Analytics" . The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace. FACTS AT A GLANCE What''s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to our digital archives and MarketGlass Research Platform Complimentary updates for one year Edition: 7; Released: February 2022 Executive Pool: 4019 Companies: 61 - Players covered include Amecath; AngioDynamics Inc.; B. Braun Melsungen AG; Bactiguard AB; Becton, Dickinson and Company; COOK MEDICAL LLC; Edwards Lifesciences Corporation; Guangdong Baihe Medical Technology Co., Ltd; ICU Medical, Inc.; Insung Medical Co.